Navigation Links
Wound Management Technologies, Inc. Announces Agreement with QX Partners, LLC
Date:4/21/2009

FORT WORTH, Texas, April 21 /PRNewswire-FirstCall/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), announced today that it has entered into an agreement with Quad Xenos Partners, LLC (QX Partners) to market and distribute their advanced wound care collagen product, CellerateRx(R) to federal government agencies. QX Partners is a Service Disabled Veteran Owned Small Business (SDVOB) that provides expertise and federally mandated leverage to small and mid-sized companies seeking to sell their products and services into the federal government. Their unique status and expertise in government affairs elevate their clients to the capability levels of their larger competitors for the long term. By law, a SDVOB must receive at least 3% of all government contracts and small/disadvantaged businesses warrant up to 20% of all government contracts. According to the Department of Veteran's Affairs (USAspending.gov) FY 2008, the VA spent over $5.5 billion on drugs, biologicals, and medical/surgical equipment and supplies. That did not include the potential for CellerateRx to be included into DOD medic kits, FEMA care packages, and other government agency purchases.

"We are excited about the opportunities presented by this relationship," said Cathy Bradshaw, President of Wound Care Innovations. "It will enable us to facilitate government sales in the many inpatient and outpatient VA centers around the country as well as the other government agencies." CellerateRx(R) is FDA cleared as a medical device and is indicated for all acute and chronic wounds except for 3rd degree burns.

"QX Partners is very pleased to team with Wound Care Innovations as this marks both companies' escalated engagement of the federal government-Veterans Administration hospitals in particular. We strongly believe that the combination of a Service Disabled Veteran Owned Small Business focused on selling the products of another small business is the best economic stimulus package possible," said QX Partners president, Alan B. McCain (LCDR, SC, USN, ret.) "VA doctors have long requested CellerateRx(R) to expedite wound care, and now they can buy it in greater quantities from fellow veterans."

About Wound Management Technologies, Inc.:

Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on the Company please visit the Company's Website at www.celleraterx.com.

About QX Partners, LLC:

QX Partners (www.qxpartners.com), a Service Disabled Veteran Owned Small Business based in Washington, DC, leverages our management consulting capabilities and excellent government agency knowledge to facilitate sales for small manufacturers and commodity producers across the nation. QXP specializes in aligning small businesses' products and services with the government agencies that need them most.

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

    For Further Information:
    Product Information                         Shareholder Relations
    Cathy Bradshaw                              Lucy Singleton
    President                                   Secretary
    954-315-9242                                817-820-7080


'/>"/>
SOURCE Wound Management Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. American Biotech Labs(R) Obtains FDA Approval for New Wound Care Gel Product
2. Wounded Warrior Project (WWP) Concerned by Stigma of PTSD and Mental Illness in Military
3. Harris Corporation Donates $10,000 to Wounded Warrior Project during HIMSS09 Healthcare IT Conference and Exposition
4. Wounded Warrior Project (WWP) Applauds Senators Akaka and Burr for Family Caregiver Support Legislation and Pledges to Support the Bill
5. Altrazeal(TM) Clinical Evidence to be Presented at The American Professional Wound Care Association (APWCA) National Clinical Conference 2009
6. Wound, Ostomy & Continence Nurses Society Focuses On Preparing the Next Generation of Leaders
7. Superbug risk to war wounded
8. ACell and Medline Announce Exclusive Marketing and Distribution Agreement for MatriStem(TM) Proprietary Bioscaffold for Wound Care
9. Wound Management Technologies Exhibits at Premier International Diabetic Foot Conference DFCon 09
10. Arobella Medical Announces European CE Mark Approval of Qoustic Wound Therapy System(TM)
11. The American Legion Strongly Opposed to Presidents Plan to Charge Wounded Heroes for Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: BPMX) ... developed an innovative way to use nonlinear optical imaging ... of new drugs. ... Conference will show how researchers from BioPharmX and the ... School used a suite of imaging techniques in what ...
(Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
(Date:10/4/2017)... , Oct. 4, 2017 OBP ... self-contained, illuminating medical devices, today announced regulatory approval ... Surveillance Agency (or Agência Nacional de Vigilância Sanitária ... single-use, cordless surgical retractor with integrated LED light ... access, illumination and exposure of a tissue pocket ...
Breaking Medicine Technology: